Heparin recall spreads in Europe
France, Italy and Denmark are recalling heparin after an Italian firm purchased contaminated ingredients from China, EU drug regulators said.
The drug has already been recalled in Germany and the United States.
The Wall Street Journal reported China's Shenzhen Hepalink Pharmaceutical Co., which supplies ingredients to U.S.-based APP Pharmaceuticals also supplied Italian company Opocrin. The Italian company said Tuesday it bought some ingredients from Shenzhen that turned out to be contaminated, the newspaper said.
APP said the Italian heparin ingredients were obtained through a different pig slaughterhouse and that APP heparin produced in the United States has consistently tested contaminant-free.
Copyright 2008 by United Press International
Citation:
Heparin recall spreads in Europe (2008, March 27)
retrieved 19 April 2024
from https://medicalxpress.com/news/2008-03-heparin-recall-europe.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
